跳至主要内容
临床试验/NCT01389453
NCT01389453撤回2 期

Umbilical Cord Mesenchyma Stem Cell Transplantation in Patients With Cerebral Hemorrhage and Cerebral Infarction

General Hospital of Chinese Armed Police Forces1 个研究点 分布在 1 个国家开始时间: 2011年4月1日最近更新:
适应症

试验速览

阶段
2 期
状态
撤回
发起方
试验地点
1
主要终点
NIHSS and FIM

研究概览

简要总结

All experimental group patients of 100 patients accept a treatment course stem cell transplantation, including one time stem cell transplantation through intravenous injection way at the 10-21th day of cerebral hemorrhage, and the 7-14th day of cerebral infarction incidence; the second time transplantation through lumbar puncture way at the 7th day after the First time transplantation. The control group gives injection through intravenous and lumbar puncture ways separately in the corresponding time, but the transplantation matter is physiological saline not the stem cell.

详细描述

The control group of 20 patients accept injection through intravenous and lumbar puncture ways separately in the corresponding time, but the transplantation matter is physiological saline not the stem cell.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Factorial
主要目的
Treatment
盲法
None

入排标准

年龄范围
40 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All tested patients with cerebral infarction, cerebral hemorrhage must tally with the diagnosis standard which in 1995 the Chinese fourth session of brain blood vessel of academic conference formulated, and after the head CT, MRI confirmation. All patients should be taken bad completely within for 24 hours.
  • patient's age and gender: 40-65years,the gender is not limit;
  • the hemorrhage, block region:One side basis festival area, one side brain stem;
  • the patient must catch the apoplexy at the first time and the accidence causes the obvious clinical symptoms.

排除标准

  • Progressive apoplexy;
  • other internal organs strict illness sickness, like serious heart disease, diabetes, liver, kidney vigorous sickness and so on;
  • the patient with tumor in every system on there body;
  • Having the primary or the sequential epilepsy medical history, within one year had the epileptic paroxysm;
  • can not accept MRI inspection, for some metal implant in there body(such as inner support in heart or brain blood vessel).

结局指标

主要结局

NIHSS and FIM

时间窗: before the transplant and after the transplant 1, 2 and 3 months

All patients should receive the American State-run Health Research institute apoplexy meter (NIHSS)evaluation, the Fugl-Meyer evaluation, the function independence evaluation (FIM) separately before the transplant and after the transplant 1, 2 and 3 months , and the grading has the distinct improvement;

次要结局

  • Motor evoked potential and sensation evoked potential inspection(before the transplant and after the transplant 0, 1, 3, 6 and 12 months)
  • MRI+ DWI+ enhancement scanning(before the transplant and after the transplant 0, 1, 3, 6 and 12 months)

研究者

发起方
General Hospital of Chinese Armed Police Forces
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验